309 related articles for article (PubMed ID: 28488260)
41. The use of extracorporeal photopheresis for allograft rejection in liver transplant recipients.
Urbani L; Mazzoni A; Catalano G; De Simone P; Vanacore R; Pardi C; Bortoli M; Biancofiore G; Campani D; Perrone V; Mosca F; Scatena F; Filipponi F
Transplant Proc; 2004 Dec; 36(10):3068-70. PubMed ID: 15686696
[TBL] [Abstract][Full Text] [Related]
42. ECP as additional immunomodulation in idiopathic hyperammonemia and recurrent hypercapnic respiratory failure early post lung transplantation.
Steinack C; Robinson CA; Nägeli M; Inci I; Benden C
J Clin Apher; 2021 Feb; 36(1):186-188. PubMed ID: 32838480
[TBL] [Abstract][Full Text] [Related]
43. Validation of a post-transplant chronic lung allograft dysfunction classification system.
Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R
J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
[TBL] [Abstract][Full Text] [Related]
44. Lung clearance index is sensitive to small airway disease in pediatric lung transplant recipients.
Kao JE; Zirbes JM; Conrad CK; Milla CE
J Heart Lung Transplant; 2017 Sep; 36(9):980-984. PubMed ID: 28651906
[TBL] [Abstract][Full Text] [Related]
45. Improved survival but marginal allograft function in patients treated with extracorporeal membrane oxygenation after lung transplantation.
Hartwig MG; Walczak R; Lin SS; Davis RD
Ann Thorac Surg; 2012 Feb; 93(2):366-71. PubMed ID: 21962264
[TBL] [Abstract][Full Text] [Related]
46. Role for CD4(+)CD25(+) T cells in inhibition of graft rejection by extracorporeal photopheresis.
George JF; Gooden CW; Guo L; Kirklin JK
J Heart Lung Transplant; 2008 Jun; 27(6):616-22. PubMed ID: 18503960
[TBL] [Abstract][Full Text] [Related]
47. Use of CT-SCAN score and volume measures to early identify restrictive allograft syndrome in single lung transplant recipients.
Philippot Q; Debray MP; Bun R; Frija-Masson J; Bunel V; Morer L; Roux A; Picard C; Jebrak G; Dauriat G; Castier Y; Cazes A; Mal H; Taupin JL; Couffignal C; Brugière O
J Heart Lung Transplant; 2020 Feb; 39(2):125-133. PubMed ID: 31836403
[TBL] [Abstract][Full Text] [Related]
48. Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS).
Verleden SE; Vandermeulen E; Ruttens D; Vos R; Vaneylen A; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM; Verleden GM
Semin Respir Crit Care Med; 2013 Jun; 34(3):352-60. PubMed ID: 23821509
[TBL] [Abstract][Full Text] [Related]
49. Chronic lung allograft dysfunction after lung transplantation: the moving target.
Sato M
Gen Thorac Cardiovasc Surg; 2013 Feb; 61(2):67-78. PubMed ID: 23138970
[TBL] [Abstract][Full Text] [Related]
50. Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction.
Leuschner G; Lauseker M; Howanietz AS; Milger K; Veit T; Munker D; Schneider C; Weig T; Michel S; Barton J; Meiser B; Dinkel J; Neurohr C; Behr J; Kneidinger N
J Heart Lung Transplant; 2020 Nov; 39(11):1270-1278. PubMed ID: 32917480
[TBL] [Abstract][Full Text] [Related]
51. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation.
Davis RD; Lau CL; Eubanks S; Messier RH; Hadjiliadis D; Steele MP; Palmer SM
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):533-42. PubMed ID: 12658195
[TBL] [Abstract][Full Text] [Related]
52. Extracorporeal photopheresis for the treatment of lung allograft rejection.
Villanueva J; Bhorade SM; Robinson JA; Husain AN; Garrity ER
Ann Transplant; 2000; 5(3):44-7. PubMed ID: 11233043
[TBL] [Abstract][Full Text] [Related]
53. Disease progression in patients with the restrictive and mixed phenotype of Chronic Lung Allograft dysfunction-A retrospective analysis in five European centers to assess the feasibility of a therapeutic trial.
Gottlieb J; Verleden GM; Perchl M; Valtin C; Vallee A; Brugière O; Bravo C
PLoS One; 2021; 16(12):e0260881. PubMed ID: 34941934
[TBL] [Abstract][Full Text] [Related]
54. Current views on chronic rejection after lung transplantation.
Verleden GM; Vos R; Vanaudenaerde B; Dupont L; Yserbyt J; Van Raemdonck D; Verleden S
Transpl Int; 2015 Oct; 28(10):1131-9. PubMed ID: 25857869
[TBL] [Abstract][Full Text] [Related]
55. Extracorporeal photopheresis in heart transplant rejection.
Patel J; Klapper E; Shafi H; Kobashigawa JA
Transfus Apher Sci; 2015 Apr; 52(2):167-70. PubMed ID: 25748232
[TBL] [Abstract][Full Text] [Related]
56. Azithromycin prophylaxis after lung transplantation is associated with improved overall survival.
Li D; Duan Q; Weinkauf J; Kapasi A; Varughese R; Hirji A; Lien D; Meyer S; Laing B; Nagendran J; Halloran K
J Heart Lung Transplant; 2020 Dec; 39(12):1426-1434. PubMed ID: 33041181
[TBL] [Abstract][Full Text] [Related]
57. Potential applications of extracorporeal photopheresis in liver transplantation.
Urbani L; Mazzoni A; Colombatto P; Biancofiore G; Bindi L; Tascini C; Menichetti F; Brunetto M; Scatena F; Filipponi F
Transplant Proc; 2008 May; 40(4):1175-8. PubMed ID: 18555142
[TBL] [Abstract][Full Text] [Related]
58. Peripheral CD4(+)CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients.
Meloni F; Cascina A; Miserere S; Perotti C; Vitulo P; Fietta AM
Transplant Proc; 2007; 39(1):213-7. PubMed ID: 17275508
[TBL] [Abstract][Full Text] [Related]
59. Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients.
Dusmet M; Maurer J; Winton T; Kesten S
J Heart Lung Transplant; 1996 Sep; 15(9):948-54. PubMed ID: 8889991
[TBL] [Abstract][Full Text] [Related]
60. Extracorporeal photopheresis for the treatment of graft rejection in 33 adult kidney transplant recipients.
Tamain M; Sayegh J; Lionet A; Grimbert P; Philipponnet C; Hazzan M; Augusto JF; Büchler M; Merlin E; Kosmadakis G; Tiple A; Pereira B; Garrouste C; Heng AE
Transfus Apher Sci; 2019 Aug; 58(4):515-524. PubMed ID: 31383541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
